Literature DB >> 7471362

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.

C Kawai, T Konishi, E Matsuyama, H Okazaki.   

Abstract

Diltiazem, verapamil and nifedipine suppress sinoatrial (SA) nodal function in the excised rabbit heart. Clinically, however, their suppressive effect on the SA node is modified considerably by the reflex increase in sympathetic tone as a result of the fall in blood pressure caused by the vasodilating action of the calcium antagonists. Diltiazem, verapamil and nifedipine suppress atrioventricular (AV) nodal conduction and prolong refractory periods in the excised rabbit AV node. Clinically, diltiazem and verapamil exert a similar suppressive effect on the AV node and are useful for treating and preventing AV nodal reentrant tachycardia. Nifedipine, in clinically practical doses, has no antiarrhythmic properties, probably because of reflex activation of the sympathetic system secondary to its hypotensive effect, which is greater than that of the other two calcium antagonists. Diltiazem and verapamil may sometimes worsen AV conduction, especially in patients with conduction disturbances. Nifedipine, on the other hand, can be used as a coronary vasodilator with the least untoward effect on AV conduction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7471362     DOI: 10.1161/01.cir.63.5.1035

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

1.  Calcium antagonists: A new class of therapeutic agents.

Authors:  Antonius Gunawan; Ali Massumi; Robert J. Hall
Journal:  Cardiovasc Dis       Date:  1981-09

2.  The effects of verapamil on cerebrospinal fluid pressure in surgical patients.

Authors:  T Nishikawa; A Namiki
Journal:  J Anesth       Date:  1987-09-01       Impact factor: 2.078

3.  Effect of diltiazem on hypoxic pulmonary vasoconstriction in dogs.

Authors:  T Okutomi; C Wakabayashi; K Ikeda
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

4.  Action of nifedipine in ischemic heart disease.

Authors:  D D Miller; P Théroux; D D Waters; G B Pelletier
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

5.  Non invasive study of systemic and regional haemodynamic and cardiac effects of a new calcium antagonist, SR 33557, in healthy volunteers.

Authors:  E Bellissant; C Thuillez; R Kechrid; P Duhaze; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Case files of the medical toxicology fellowship training program at the New York city poison control center: hypotensive death--therapeutic complication or suicide?

Authors:  S Eliza Halcomb; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2006-06

Review 7.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 8.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

9.  The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.

Authors:  M B Maltz; D W Davies; C P Lau; J E Creamer; S O Banim; A J Camm
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

10.  Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study.

Authors:  F Bari; G Horváth; G Benedek
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.